| 注册
首页|期刊导航|重庆医学|VEGF、PCNA及Survivin与膀胱癌病理分级、临床分期的关系

VEGF、PCNA及Survivin与膀胱癌病理分级、临床分期的关系

况南珍 傅颖媛 黄红卫 王福财 曾小平

重庆医学2012,Vol.41Issue(7):651-653,封3,4.
重庆医学2012,Vol.41Issue(7):651-653,封3,4.DOI:10.3969/j.issn.1671-8348.2012.07.009

VEGF、PCNA及Survivin与膀胱癌病理分级、临床分期的关系

Relationship of VEGF,PCNA,Survivin and pathological grading,clinical stage of bladder cancer*

况南珍 1傅颖媛 1黄红卫 2王福财 1曾小平1

作者信息

  • 1. 南昌大学基础医学院免疫学教研室,江西南昌,330006
  • 2. 南昌大学第二附属医院泌尿外科,江西南昌,330006
  • 折叠

摘要

Abstract

Objective To explore the expression of vascular endothelial growth factor(VEGF) proliferating cell nuclear antigen (PCNA)and Survivin in bladder tumor tissue and their clinical significance. Methods Immunohistochemistry streptavidin-perosi-dase(SP) method was employed to detect the expression of VKGF,PCNA and Survivin in tissue of 50 cases of bladder transitional cell carcinoma and 10 cases of normal bladder. Results Positive expression rates of VEGF,PCNA and Survivin in bladder tumor tissue were 56. 1% (23/41),56.5% (26/46) and 60. 0% (27/45) respectively, which were significantly higher than those in normal bladder tissue(P<0. 01) and increased with increasing pathological grading and clinical stage of bladder tumor(P<0. 01). Conclusion Positive expression of VKGF,PCNA and Survivin have close relationship with the bladder tumorigenesis and development.

关键词

血管内皮生长因子类/增殖细胞核抗原/免疫组织化学/Survivin/膀胱肿瘤

Key words

vascular endothelial growth factors/proliferating cell nuclear antigen/immunohistochemistry/Survivin/bladder neo-plasms

引用本文复制引用

况南珍,傅颖媛,黄红卫,王福财,曾小平..VEGF、PCNA及Survivin与膀胱癌病理分级、临床分期的关系[J].重庆医学,2012,41(7):651-653,封3,4.

基金项目

江西省教育厅科学技术研究基金资助项目[赣教技字(2006)66号]. (2006)

重庆医学

OA北大核心CSCDCSTPCD

1671-8348

访问量0
|
下载量0
段落导航相关论文